Canada markets open in 2 hours

Teladoc Health, Inc. (TDOC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
18.43-0.16 (-0.86%)
At close: 04:00PM EDT
18.22 -0.21 (-1.14%)
Pre-Market: 07:19AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close18.59
Bid18.30 x 1000
Ask18.43 x 2200
Day's Range18.04 - 18.52
52 Week Range18.04 - 34.73
Avg. Volume5,660,117
Market Cap3.04B
Beta (5Y Monthly)1.10
PE Ratio (TTM)N/A
EPS (TTM)-24.33
Earnings DateOct 24, 2023 - Oct 30, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est29.39
  • Motley Fool

    Is Hims & Hers Health Stock a Buy Now?

    Share prices of direct-to-consumer healthcare company Hims & Hers Health (NYSE: HIMS) started hot in 2023, doubling from $6 per share to $12. Here is why this stock is an opportunity you don't want to miss. Hims & Hers is a digital healthcare platform where patients can consult professionals for several conditions and receive personalized scripts sent to their homes.

  • Zacks

    Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know

    Teladoc (TDOC) closed the most recent trading day at $18.43, moving -0.86% from the previous trading session.

  • Motley Fool

    2 Stocks Under $25 to Buy and Hold for 10 Years

    The company's current lineup includes the t:slim X2 and the newly cleared Mobi Insulin Pump, which management calls "the world's smallest durable insulin delivery system." Despite this progress on the regulatory front, Tandem has been bruised and battered on the stock market over the past year, as its financial results haven't been as good. The company's sales of insulin pumps have declined amid the challenging economy, leading to lower year-over-year revenue growth.